# Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

> **NCT00003854** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 4590 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** immunohistochemistry staining method
- **PROCEDURE:** lymphangiography
- **PROCEDURE:** sentinel lymph node biopsy
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** whole breast irradiation

## Key facts

- **NCT ID:** NCT00003854
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2006-08
- **Final completion:** 2011-07
- **Target enrollment:** 4590 (ACTUAL)
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003854, "Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00003854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*